Allscripts Acquires Oasis Medical Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care. By combining the Oasis PAS technology with the Allscripts Sunrise clinical platform, Allscripts will offer a highly competitive, single-source offering for an innovative and advanced electronic patient record solution throughout the United Kingdom.

The Oasis PAS is used extensively across the NHS in more than a dozen NHS trusts and hospitals. Clients include East Sussex Healthcare, Royal Surrey County Hospital Trust, Medway NHS Foundation Trust and Worcestershire Acute Hospitals NHS Trust, among others. Oasis hospital clients average over 500 beds per facility, and the company has distinguished itself for its exclusive focus on PAS solutions for the NHS trusts that are innovative, effective, affordable and flexible.

Allscripts has a proven track record of success for clinical solutions, specifically the Allscripts Sunrise clinical electronic health record for inpatient and outpatient care management. Today, Sunrise is live at Liverpool Heart and Chest Hospital NHS Foundation Trust as well as at Salford Royal NHS Foundation Trust. In addition, Allscripts recently announced the opening of its European headquarters in Manchester, UK, committing additional resources to this important healthcare market.

By combining a leading PAS offering with its advanced clinical solution, Allscripts will provide the UK NHS trusts with the clear long-term advantages of integrated workflow between PAS and clinical solutions and the benefit of one business partner that provides a single-source electronic patient record to improve the efficiency and quality of healthcare delivery.

"The United Kingdom is an important growth market for Allscripts core clinical and PAS solutions," said Richard Berner, President, Allscripts International. "A strong clinical offering combined with a highly regarded PAS provides a complete and proven solution to meet the critical long-term needs of the NHS Trusts. By acquiring Oasis, we believe we have optimised our position in the market and expect to drive significant value from this combination for our clients."

Terms of the acquisition were not disclosed.

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...